You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

CD40L

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Carcinoma, Squamous Cell, Head and Neck Tumor, Cervical Tumor Trial in Southampton (BNT113)

Recruiting
  • Carcinoma, Squamous Cell
  • +3 more
  • Southampton, Hampshire, United Kingdom
    Univeristy Hospitals Southampton NHS Foundation Trust
May 17, 2022

Glioma, Malignant Trial in Durham (D2C7-IT, 2141-V11)

Recruiting
  • Glioma, Malignant
  • Durham, North Carolina
    Duke University Medical Center
Jul 27, 2022

Malignant Solid Tumor Trial (GEN1042, Pembrolizumab, Cisplatin)

Not yet recruiting
  • Malignant Solid Tumor
  • GEN1042
  • +4 more
  • (no location specified)
Sep 21, 2023

Metastatic Pancreatic Cancer Trial in Rotterdam (MesoPher, Mitazalimab)

Recruiting
  • Metastatic Pancreatic Cancer
  • MesoPher
  • Mitazalimab
  • Rotterdam, Zuid-Holland, Netherlands
    Erasmus MC
Dec 6, 2022

Obesity Trial in Cork (Probiotic capsule (L. reuteri PB-W1™), Placebo sachet, Prebiotic sachet (Prebiotic Blend), Placebo

Recruiting
  • Obesity
  • Probiotic capsule (L. reuteri PB-W1™), Placebo sachet
  • +3 more
  • Cork, Ireland
    University College Cork
Jul 5, 2023

Cancer Trial in Houston (LVGN7409)

Recruiting
  • Cancer
  • LVGN7409
  • Houston, Texas
    MD Anderson Cancer Center
Apr 4, 2022

Psoriasis Trial in Canada, United States (CD 2027, Calcitriol Vehicle)

Completed
Has Results
  • Psoriasis
  • CD 2027
  • Calcitriol Vehicle
  • Fridley, Minnesota
  • +5 more
Jul 26, 2022

Leukemia Trial in Tampa (lenalidomide, bystander vaccine)

Completed
  • Leukemia
  • Tampa, Florida
    H. Lee Moffitt Cancer Center & Research Institute
Dec 10, 2019

Advanced Malignant Tumor Trial in Guangzhou (BAT7104 injection)

Recruiting
  • Advanced Malignant Tumor
  • BAT7104 injection
  • Guangzhou, Guangdong, China
    Li Zhang
Mar 1, 2023

Metastatic Non-Small Cell Lung Carcinoma Trial in Seoul (Pembrolizumab Injection)

Recruiting
  • Metastatic Non-Small Cell Lung Carcinoma
  • Pembrolizumab Injection
  • Seoul, Korea, Republic of
    Samsung Medical Center
Nov 6, 2022

Advanced Solid Tumor, NSCLC, Small Cell Lung Cancer Trial (IMM2520)

Not yet recruiting
  • Advanced Solid Tumor
  • +5 more
  • (no location specified)
Mar 20, 2023

Melanoma, Carcinoma, Non-Small- Cell Lung Trial in Worldwide (SEA-CD40, pembrolizumab, pemetrexed)

Recruiting
  • Melanoma
  • Carcinoma, Non-Small- Cell Lung
  • Springdale, Arkansas
  • +18 more
Mar 11, 2022

Acute Lymphoblastic Leukemia, Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia Trial in Vancouver, Ottawa (CLIC-1901)

Recruiting
  • Acute Lymphoblastic Leukemia
  • +2 more
  • CLIC-1901
  • Vancouver, British Columbia, Canada
  • +1 more
Mar 26, 2022

Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Houston (Anti-OX40 Agonist Monoclonal Antibody

Active, not recruiting
  • Recurrent Acute Myeloid Leukemia
  • Refractory Acute Myeloid Leukemia
  • Anti-OX40 Agonist Monoclonal Antibody PF-04518600
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 25, 2022

Colorectal Tumors Trial in Portland (MEDI6469)

Terminated
  • Colorectal Neoplasms
  • Portland, Oregon
    Portland Providence Medical Center
Jan 31, 2022

Plasma Cell Myeloma Trial in Seattle (biological, drug, procedure)

Recruiting
  • Plasma Cell Myeloma
  • Astatine At 211 Anti-CD38 Monoclonal Antibody OKT10-B10
  • +2 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jul 27, 2022

Kidney Transplant Rejection Trial in Worldwide (CFZ533 - MMF - CS, Tacrolimus - MMF - +/- corticosteroids)

Completed
  • Kidney Transplant Rejection
  • CFZ533 - MMF - CS
  • Tacrolimus - MMF - +/- corticosteroids
  • Los Angeles, California
  • +73 more
Jun 8, 2022

Pathophysiology of Non-infectious Active Uveitis

Recruiting
  • Non-Infectious Active Uveitis
  • s-CD95-L
  • Bordeaux, France
    CHU Bordeaux
Apr 11, 2022

Periodontitis Trial in Poltava (Scaling and root planing, Oral L-arginine aspartate administration, Oral L-ornithine aspartate

Completed
  • Periodontitis
  • Scaling and root planing
  • +2 more
  • Poltava, Ukraine
    Ukrainian Medical Stomatological Academy
Sep 11, 2021

ICD10 Code L40.9 for Psoriasis Trial in Winston-Salem (Betamethasone dipropionate 0.05%, Tapinarof)

Not yet recruiting
  • ICD10 Code L40.9 for Psoriasis
  • Winston-Salem, North Carolina
    Wake Forest University Health Sciences Department of Dermatology
Jul 31, 2023

Cancer Trial in Beijing (LVGN7409)

Recruiting
  • Cancer
  • LVGN7409
  • Beijing, Beijing, China
    Center Hospital Chinese Academy of Medical Sciences
Dec 7, 2021

Esophageal Adenocarcinoma, Oesophageal Adenocarcinoma, Resectable Carcinoma Trial in Amsterdam (Tocilizumab 20 Mg/mL Intravenous

Active, not recruiting
  • Esophageal Adenocarcinoma
  • +2 more
  • Tocilizumab 20 Mg/mL Intravenous Solution
  • +3 more
  • Amsterdam, Netherlands
    Academic Medical Center, Medical Oncology
Dec 15, 2022

COL6A3 Positive, HLA-A*0201 Positive Cells Present, PRAME Positive Trial in Houston (biological, drug, procedure)

Active, not recruiting
  • COL6A3 Positive
  • +3 more
  • Aldesleukin
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Sep 22, 2022

Non-CNS Tumor Trial (biological, drug, radiation)

Not yet recruiting
  • Non-CNS Tumor
  • GEN1042
  • +2 more
  • (no location specified)
Aug 4, 2022

Hidradenitis Suppurativa Trial (SAR442970, Placebo)

Not yet recruiting
  • Hidradenitis Suppurativa
  • (no location specified)
Apr 28, 2023